Vivian Campbell’s shock – Hodgkin’s returns after transplant fails

Vivian Campbell, the 63‑year‑old guitarist of Def Leppard, announced that his Hodgkin’s lymphoma has recurred following a donor transplant in January 2025. The musician disclosed the setback on El Salvadoran radio station YSKL, explaining that the transplant “didn’t stick” and that additional treatment is planned.

The band’s veteran guitarist began his battle with the disease when he was first diagnosed in 2013, and it re‑appeared two years later. A transplant was pursued as a last‑resort measure, but the effort proved unsuccessful.

Campbell’s remarks emphasize his determination to continue performing while managing the illness, a sentiment that has resonated with fans across the globe.

---

## Background & Context

Campbell’s cancer history began with a diagnosis of Hodgkin’s lymphoma in 2013, a type of lymphatic system cancer that is often curable with chemotherapy and radiation. The disease returned in 2015, prompting an intensified treatment regimen that included high‑dose chemotherapy followed by autologous stem‑cell rescue.

Despite initial remission, the cancer’s aggressive nature kept him on a watchful path.

In late 2023, Campbell reported a sudden acceleration of symptoms—swelling in the neck, night sweats, and unexplained fatigue—that led him to seek a donor transplant. He received an allogeneic bone‑marrow transplant from a matched unrelated donor in January 2025.

The procedure was technically successful in terms of engraftment, but imaging studies revealed that lymphoma cells had persisted in his lymph nodes. The failure of the transplant underscored the complexity of treating relapsed Hodgkin’s lymphoma, even after cutting‑edge therapies.

Campbell has always been open about his health journey. He first announced his diagnosis to the press in 2013, expressing gratitude for the support of his bandmates and fans. Over the years, he has maintained a rigorous touring schedule—playing every night of a 30‑day tour in 2022—while attending regular medical appointments.

His dual role as a high‑energy performer and cancer patient has become a symbol of resilience within the rock community.

---

## What People Are Saying

In his interview,

Campbell urged others diagnosed with cancer to “keep moving forward.” He emphasized that “I could still continue to work, that gives me something to live for—something that you enjoy, that you’re passionate about, that you can wake up in the morning and look forward to.” The musician added, “Life is for the living, and I encourage everyone to look after their own health,” and encouraged those with cancer “just don’t give in.”

Fans flooded YSKL’s social‑media channels with messages of support.

---

## What Happens Next

, he will pursue another transplant in the coming years if necessary. While the transplant in January 2025 failed, he continues with other treatments “to manage it.” Def Leppard’s schedule includes a show on October 15 in Hollywood, Florida, followed by a month‑long Latin American tour.

---

## Legacy and Industry Impact

Campbell’s candidness has brought attention to his personal struggle with Hodgkin’s lymphoma. He continues to perform and share his experience, offering insight into the realities of treating this disease and serving as an inspiration for fans and fellow patients alike.

Vivian Campbell remains an active figure in rock music, balancing his health struggles with a commitment to performance. His public statements not only provide insight into the realities of treating Hodgkin’s lymphoma but also serve as an inspiration for fans and fellow patients alike.

As he continues his tour, the world watches with admiration, eager to see how he will turn adversity into an encore that echoes for years to come.